Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

Similar articles for PubMed (Select 19775288)

1.

SIAH1 induced apoptosis by activation of the JNK pathway and inhibited invasion by inactivation of the ERK pathway in breast cancer cells.

Wen YY, Yang ZQ, Song M, Li BL, Zhu JJ, Wang EH.

Cancer Sci. 2010 Jan;101(1):73-9. doi: 10.1111/j.1349-7006.2009.01339.x. Epub 2009 Sep 2.

PMID:
19775288
2.

The expression of SIAH1 is downregulated and associated with Bim and apoptosis in human breast cancer tissues and cells.

Wen YY, Yang ZQ, Song M, Li BL, Yao XH, Chen XL, Zhao J, Lu YY, Zhu JJ, Wang EH.

Mol Carcinog. 2010 May;49(5):440-9. doi: 10.1002/mc.20615.

PMID:
20082325
4.

Modulation of multidrug resistance in cancer cells by the E3 ubiquitin ligase seven-in-absentia homologue 1.

Liu M, Aneja R, Wang H, Sun L, Dong X, Huo L, Joshi H, Zhou J.

J Pathol. 2008 Mar;214(4):508-14. doi: 10.1002/path.2312.

PMID:
18213731
5.

Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.

Park HJ, Kim BC, Kim SJ, Choi KS.

Hepatology. 2002 Jun;35(6):1360-71.

PMID:
12029621
8.
9.

PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax.

Wang T, Lee K, Rehman A, Daoud SS.

Biochem Biophys Res Commun. 2007 Jan 5;352(1):203-12. Epub 2006 Nov 9.

PMID:
17113036
11.

Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells.

Yu JH, Wang HJ, Li XR, Tashiro S, Onodera S, Ikejima T.

Acta Pharmacol Sin. 2008 Sep;29(9):1069-76. doi: 10.1111/j.1745-7254.2008.00835.x.

12.

Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells.

McMurtry V, Simeone AM, Nieves-Alicea R, Tari AM.

Clin Exp Metastasis. 2009;26(3):197-204. doi: 10.1007/s10585-008-9231-x. Epub 2008 Dec 27.

PMID:
19112600
13.

Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.

Cheng Y, Qiu F, Ye YC, Tashiro S, Onodera S, Ikejima T.

Arch Biochem Biophys. 2009 Oct 1;490(1):70-5. doi: 10.1016/j.abb.2009.08.011. Epub 2009 Aug 20.

PMID:
19699177
14.

ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.

Sabbagh L, Pulle G, Liu Y, Tsitsikov EN, Watts TH.

J Immunol. 2008 Jun 15;180(12):8093-101.

15.

[Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].

Han YC, Zeng XX, Wang R, Zhao Y, Li BL, Song M.

Ai Zheng. 2007 Jan;26(1):48-53. Chinese.

PMID:
17222367
16.

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.

Adv Enzyme Regul. 2006;46:249-79. Epub 2006 Jul 18.

PMID:
16854453
17.

Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.

Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ.

Eur J Pharmacol. 2007 Jun 1;563(1-3):49-60. Epub 2007 Feb 8.

PMID:
17341418
18.

Ceramide promotes apoptosis in lung cancer-derived A549 cells by a mechanism involving c-Jun NH2-terminal kinase.

Kurinna SM, Tsao CC, Nica AF, Jiffar T, Ruvolo PP.

Cancer Res. 2004 Nov 1;64(21):7852-6.

19.

Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway.

Cao XH, Wang AH, Wang CL, Mao DZ, Lu MF, Cui YQ, Jiao RZ.

Chem Biol Interact. 2010 Feb 12;183(3):357-62. doi: 10.1016/j.cbi.2009.11.027. Epub 2009 Nov 30.

PMID:
19954742
20.

Lack of somatic mutation in the coding sequence of SIAH1 in tumors hemizygous for this candidate tumor suppressor gene.

Medhioub M, Vaury C, Hamelin R, Thomas G.

Int J Cancer. 2000 Sep 15;87(6):794-7.

PMID:
10956387
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk